Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
|
|
Express Scripts Holding Co. (ESRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/31/2018 |
8-K
| Quarterly results |
| 08/01/2018 |
8-K
| Quarterly results|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : August 1, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2018 Second Quarter Results - Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Claims Growth for 2019 ST. LOUIS, August 1, 2018 — Express Scripts Holding Company announced consolidated 2018 second quarter net income of $877.3 million or $1.55 per diluted share. Consolidated 2018 second quarter adjusted earnings per diluted share were $2.22, which represents growth of 28% over consolidated 2017 second quarter adjusted earnings per diluted share.* The Company increased its 2018 core business¹ adjusted EBITDA* guidance from a range of $5,250 million to $5,400 million to a range of $5,275 million to $5,425 million, which represents growth of..." |
|
| 05/02/2018 |
8-K
| Quarterly results|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : May 2, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2018 First Quarter Results ST. LOUIS, May 2, 2018 — Express Scripts Holding Company announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated 2018 first quarter adjusted earnings per diluted share was $1.77.* The Company reaffirms its core business¹ 2018 adjusted EBITDA* guidance in the range of $5,250 million to $5,400 million, which represents growth of 8% over core business 2017 adjusted EBITDA at the midpoint of the range. “Our first quarter results reflect our success in driving greater value for clients, delivering better health outcomes for patients and growth in earnings for shareholders,” said Tim Wentworth, President and CEO. “Express Scripts' focused business model, our innovative solutions and unmat..." |
|
| 02/27/2018 |
8-K
| Quarterly results|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : February 27, 2018 EXPRESS SCRIPTS HOLDING COMPANY DELAWARE 001-35490 45-2884094 One Express Way, St. Louis, MO 63121 Registrant's telephone number including area code: 314-996-0900 No change since last report",
"Express Scripts Announces 2017 Fourth Quarter and Full Year Results ST. LOUIS, February 27, 2018 — Express Scripts Holding Company announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million and $4,517.4 million, respectively, or $4.10 and $7.74 per diluted share, respectively. Consolidated 2017 fourth quarter and full year adjusted earnings per diluted share were $2.16 and $7.10, respectively.* “Throughout 2017, Express Scripts kept our patients and clients ahead of the curve by providing best-in-class solutions. These solutions limited prescription drug spending growth to an average of 1.5% over 2016, a record low, for commercial plans,” said Tim Wentworth, President and CEO. “We have also seen a strong start to 2018, with outstanding client implementations, a..." |
|
| 10/24/2017 |
8-K
| Quarterly results |
| 07/25/2017 |
8-K
| Form 8-K - Current report: |
| 04/24/2017 |
8-K
| Form 8-K - Current report |
| 02/14/2017 |
8-K
| Form 8-K - Current report |
| 10/25/2016 |
8-K
| Form 8-K - Current report |
| 07/25/2016 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance ST. LOUIS, July 25, 2016 — Express Scripts Holding Company announced 2016 second quarter net income of $720.7 million, or $1.13 per diluted share. 2016 second quarter adjusted earnings per diluted share, as detailed in Table 4, was $1.57. 1 “As the healthcare industry changes, a primary need of payers and patients remains the same: access to affordable medicine,” said Tim Wentworth, CEO and President. “An increase in our expected 2017 retention rate to a range of 96% to 98% is a direct result of our unique business model of client alignment, the industry's most focused and innovative solutions, and a compassionate culture ..." |
|
| 04/25/2016 |
8-K
| Form 8-K - Current report |
| 02/16/2016 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 2015 4th Quarter and Full Year Results; Narrows 2016 Guidance Range: Raises Mid-Point ST. LOUIS, February 16, 2016 — Express Scripts Holding Company announced 2015 fourth quarter and full year net income of $773.5 million and $2,476.4 million, respectively, or $1.13 and $3.56 per diluted share. 2015 fourth quarter and full year adjusted earnings per diluted share, as detailed in Table 4, was $1.56 and $5.53, respectively. 1 “Our business model of alignment, developed 30 years ago, has never been more relevant than it is today,” said George Paz, Chairman and CEO. “Our job is to continue to take advantage of the opportunities and uniquely help clients withstand the constant challenges in the healthcare marketplace by taking bold actions to effectively balance pharma..." |
|
| 10/27/2015 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 3rd Quarter Results; Increases 2015 Guidance Range ST. LOUIS, October 27, 2015 — Express Scripts Holding Company announced 2015 third quarter net income attributable to Express Scripts stockholders of $661.7 million, or $0.97 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.45 for the third quarter. 1 “With the rising cost of prescription drugs, we are continuing our mission to make medicine more affordable and accessible for clients and patients,” said George Paz, Chairman and CEO. “Our innovative solutions, focused scale, specialized care and unmatched leadership manages cost more favorably for payers while improving health outcomes of our patients. Effective pharmacy benefit management has never been more critical to ensur..." |
|
| 07/28/2015 |
8-K
| Quarterly results |
| 04/28/2015 |
8-K
| Quarterly results|
Docs:
|
"Credit Agreement, among Express Scripts Holding Company, Credit Suisse AG, Cayman Islands Branch, as administrative agent, Citibank, N.A., as syndication agent, and the other lenders and agents named therein",
"Express Scripts Announces 1st Quarter Results; Announces New Credit Agreement; Narrows 2015 Guidance Range; Maintains Mid-Point ST. LOUIS, April 28, 2015 — Express Scripts Holding Company announced 2015 first quarter net income attributable to Express Scripts stockholders of $441.1 million, or $0.60 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.10 for the first quarter. 1 “As our industry evolves, and plan sponsors have more business models to choose from, it is increasingly clear that Express Scripts is the best choice to manage America's pharmacy benefits,” stated George Paz, Chairman and Chief Executive Officer. “At every turn, we add value to healthcare by combining a superior model of patient care with aggressive payer advocacy. Our unique com..." |
|
| 02/23/2015 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 4th Quarter Results; Provides Initial 2015 Earnings Guidance ST. LOUIS, February 23, 2015 — Express Scripts Holding Company announced 2014 fourth quarter and full year net income attributable to Express Scripts stockholders of $581.8 million and $2,007.6 million, or $0.79 and $2.64 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.39 and $4.88 for the fourth quarter and full year, respectively. 1 “While we are proud of our heritage and the work we have done for clients, we are even more excited about the future we have ahead of us,” stated George Paz, chairman and chief executive officer. “We believe our growth and focused acquisition approach has positioned us uniquely in the healthcare services landscape to improve health ou..." |
|
| 10/28/2014 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point ST. LOUIS, October 28, 2014 — Express Scripts Holding Company announced 2014 third quarter net income attributable to Express Scripts stockholders of $582.3 million, or $0.78 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, was $1.29 for the third quarter. 1 “We have continually improved the pharmacy benefit over nearly three decades, and we're positioning ourselves to drive further advances,” stated George Paz, chairman and chief executive officer. “The pharmacy benefit is the most used benefit by members and represents the biggest opportunity to add value to healthcare by making it easier to access, more affordable, safer, and more effective. Looking forward, we ..." |
|
| 07/29/2014 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point ST. LOUIS, July 29, 2014 — Express Scripts Holding Company announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, was $1.23 for the second quarter. 1 “We are well positioned to serve our clients with scale, alignment and innovative solutions to lower costs, manage trend and to improve the health outcomes of our members,” stated George Paz, chairman and chief executive officer. “We are using our scale in formulary management, regulatory compliance and personalized care through our Therapeutic Resource Centers, to control cost and provide a safe, convenient pha..." |
|
| 04/29/2014 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces 1st Quarter Results Adjusts 2014 Full Year Guidance ST. LOUIS, April 29, 2014 — Express Scripts Holding Company announced 2014 first quarter net income attributable to Express Scripts 1stockholders of $328.3 million, or $0.42 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, was $0.99 for the first quarter. “We have been focused on integration over the last several years, and as a result of this effort, we have successfully built a technology platform that singularly provides the industry's best set of patient-centric solutions and innovative tools to help manage the complex future of healthcare,” stated George Paz, chairman and chief executive officer. “Through the remainder of 2014, we will substantially complete the integration of ..." |
|
| 02/20/2014 |
8-K
| Quarterly results|
Docs:
|
"Express Scripts Announces Record 4th Quarter Adjusted EPS of $1.12; Reported EPS of $0.64 Provides Initial 2014 Earnings Guidance ST. LOUIS, February 20, 2014 — Express Scripts Holding Company announced 2013 fourth quarter and full year net income from continuing operations attributable to Express Scripts shareholders of $514.2 million and $1,898.2 million, or $0.64 and $2.31 per diluted share, respectively. Adjusted earnings per diluted share from continuing operations attributable to Express Scripts, as detailed in Table 4, were $1.12 and $4.33 for the fourth quarter and full year, respectively. “With the industry's broadest set of solutions now available on one technology platform, we enter 2014 with momentum and unique capabilities to address the needs of our clients,” stated George Pa..." |
|
| 10/24/2013 |
8-K
| Form 8-K - Current report |
| 07/29/2013 |
8-K
| Form 8-K - Current report |
| 04/29/2013 |
8-K
| Quarterly results |
| 02/19/2013 |
8-K
| Quarterly results |
| 11/05/2012 |
8-K
| Form 8-K - Current report |
| 08/07/2012 |
8-K
| Form 8-K - Current report |
| 05/10/2012 |
8-K
| Form 8-K - Current report |
|
|